Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Colonic Neoplasms × peginterferon alfa-2a × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Polycythemia Vera 3 Thrombocythemia, Essential 2 Philadelphia Chromosome 2 Neoplasm Metastasis 2 Myeloproliferative Disorders 2 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 2 Brain Neoplasms 2 Skin Neoplasms 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Pancreatic Neoplasms 1 Neoplasms 1 Neoplasm, Residual 1 Leukemia 1 Glioma 1 Colonic Neoplasms 1 Carcinoma, Squamous Cell 1 Carcinoma, Hepatocellular 1 Breast Neoplasms, Male 1 Breast Neoplasms 1 Blast Crisis 1

Interventions

Fluorouracil 80 Oxaliplatin 73 Leucovorin 73 Irinotecan 68 Bevacizumab 45 Capecitabine 39 Cetuximab 36 Panitumumab 15 Folfox protocol 15 Floxuridine 11 Chemotherapy, Adjuvant 11 IFL protocol 9 Surgical Procedures, Operative 8 Neoadjuvant Therapy 8 Drug Therapy 8 trifluridine tipiracil drug combination 7 regorafenib 7 pembrolizumab 7 XELOX 7 Nivolumab 7 Radiotherapy 6 sargramostim 5 Trastuzumab 5 Melphalan 5 Immunohistochemistry 5 Dexamethasone 5 Celecoxib 5 Biopsy 5 tislelizumab 4 aflibercept 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04798612 2023-08-18

IPOS

Zealand University Hospital

Phase 2 Unknown

Gastrointestinal

Colonic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡